• About us
  • Cleantech
  • CSCF
  • Health-tech
  • ICT
  • Quest
  • For entrepreneurs
  • Jobs
  • News
  • Contact us

mainstay

Mainstay Medical achieves Quality System Certification

on 09/12/2014 14:25
Certification is an important step towards the commercialisation of ReActiv8.
Read more

Mainstay Medical - Interim Management Statement

on 06/11/2014 10:59
Continued progress towards commercialisation of ReActiv8®
Read more

Mainstay Medical announces half year financial results

on 28/08/2014 16:20
Momentum builds towards commercialisation of ReActiv8®
Read more

Mainstay Medical Announces Pre-IDE Submission for ReActiv8® to FDA

on 07/07/2014 11:26
Mainstay Medical continues progress towards the commercialisation of ReActiv8.
Read more

Mainstay Medical to Euronext and Irish Stock Exchange

on 28/04/2014 17:35
Announcement of offer price and number of issued ordinary shares on admission to Euronext Paris and ESM.
Read more
  • Previous >
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next >
capricorn

Latest news

  • Nexstim Plc Depression Therapy Business Update
  • Capricorn Venture Partners holds final close of its Capricorn Sustainable Chemistry Fund at € 86.5 million adding new investors
  • Nexstim Plc signs Canadian distribution agreement for its SmartFocus™ TMS systems with Canadian Health Solutions CHS

Tags

arkite avantium blackbear bluebee c-lecta capricorn cartagenia ccf chf cleantech confo cscf diagenode dmc epigan euroscreen feops frx gbl health-tech icometrix ict indigo istar lindacare mainstay metallkraft nexstim ngdata noona ogeda punch sensolus sequana trinean trod virovet
  • sitemap
  • News feed
  • Privacy Policy
© Capricorn Venture Partners